ImmunityBio (IBRX) Total Debt Growth (3y) (2018 - 2026)
ImmunityBio (IBRX) Total Debt Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 50.25% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 25.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 18.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.07% |
| Sep 30, 2025 | -5.39% |
| Jun 30, 2025 | -0.59% |
| Mar 31, 2025 | -1.44% |
| Sep 30, 2024 | -29.11% |
| Jun 30, 2024 | -29.98% |
| Mar 31, 2024 | -19.66% |
| Dec 31, 2023 | -16.73% |
| Sep 30, 2023 | 110.65% |
| Mar 31, 2023 | 560.36% |
| Sep 30, 2022 | 654.82% |
| Jun 30, 2022 | 588.65% |
| Mar 31, 2022 | 486.85% |
| Sep 30, 2021 | 423.44% |
| Jun 30, 2021 | 459.88% |
| Mar 31, 2021 | 404.36% |
| Dec 31, 2020 | 384.77% |
| Sep 30, 2020 | 195.71% |
| Mar 31, 2020 | -26.22% |
| Dec 31, 2019 | -34.79% |